Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. - Piero L Olliaro; Annette C Kuesel; Christine M Halleux; Mark Sullivan; John C Reeder (Public Library of Science (PLoS), 2018)